2025 annual financial data
Immunocore Holdings 2025 Operating margin
Immunocore Holdings 2025 operating margin with verified reported values.
Direct answer
Operating margin was -11.34%.
Operating income was -33,737,839 USD and net income was -26,418,662 USD.
Operating cash flow was -7,968,595 USD.
Get free Immunocore Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 297,569,634 USD
- Operating income
- -33,737,839 USD
- Net income
- -26,418,662 USD
- Operating cash flow
- -7,968,595 USD